Medications for Opioid Dependence and Withdrawal

Opioid dependence can be treated with medications under medical supervision. Methadone and buprenorphine are two options that can be used to substitute for illicit opioids. Buprenorphine should be given when the patient is experiencing withdrawal symptoms. Benzodiazepines like lorazepam and diazepam are used to treat withdrawal symptoms but not as a substitute for opioids. Lofexidine is also used to treat withdrawal symptoms. Naltrexone, an opioid antagonist, can be used to sustain abstinence in consenting patients.

Men are more commonly affected by antisocial personality disorder, while borderline personality disorder is more frequently diagnosed in young women. However, there can be some overlap in the symptoms of both disorders, such as impulsivity. Borderline personality disorder is characterized by unstable emotions, fluctuating self-image, and recurrent thoughts of self-harm or suicide. On the other hand, antisocial personality disorder is marked by a repeated failure to follow social norms or rules, reckless behavior that endangers oneself and others, and a lack of remorse for these actions. If there are persistent mood changes or psychotic symptoms present, it may indicate a different primary diagnosis than a personality disorder.

Personality disorders are a set of personality traits that are maladaptive and interfere with normal functioning in life. It is estimated that around 1 in 20 people have a personality disorder, which are typically categorized into three clusters: Cluster A, which includes Odd or Eccentric disorders such as Paranoid, Schizoid, and Schizotypal; Cluster B, which includes Dramatic, Emotional, or Erratic disorders such as Antisocial, Borderline (Emotionally Unstable), Histrionic, and Narcissistic; and Cluster C, which includes Anxious and Fearful disorders such as Obsessive-Compulsive, Avoidant, and Dependent.

Paranoid individuals exhibit hypersensitivity and an unforgiving attitude when insulted, a reluctance to confide in others, and a preoccupation with conspiratorial beliefs and hidden meanings. Schizoid individuals show indifference to praise and criticism, a preference for solitary activities, and emotional coldness. Schizotypal individuals exhibit odd beliefs and magical thinking, unusual perceptual disturbances, and inappropriate affect. Antisocial individuals fail to conform to social norms, deceive others, and exhibit impulsiveness, irritability, and aggressiveness. Borderline individuals exhibit unstable interpersonal relationships, impulsivity, and affective instability. Histrionic individuals exhibit inappropriate sexual seductiveness, a need to be the center of attention, and self-dramatization. Narcissistic individuals exhibit a grandiose sense of self-importance, lack of empathy, and excessive need for admiration. Obsessive-compulsive individuals are occupied with details, rules, and organization to the point of hampering completion of tasks. Avoidant individuals avoid interpersonal contact due to fears of criticism or rejection, while dependent individuals have difficulty making decisions without excessive reassurance from others.

Personality disorders are difficult to treat, but a number of approaches have been shown to help patients, including psychological therapies such as dialectical behavior therapy and treatment of any coexisting psychiatric conditions.

Patients diagnosed with avoidant personality disorder exhibit a strong fear of criticism, rejection, ridicule, and being disliked. They tend to avoid social and occupational activities that involve significant interpersonal contact due to their fear of being criticized or rejected. These individuals have a negative self-image and are preoccupied with the idea that they are being criticized or rejected in social situations. Although they crave social contact, they tend to isolate themselves socially. This disorder is distinct from other personality disorders such as antisocial personality disorder, borderline personality disorder, and dependent personality disorder, which present with different symptoms and behaviors.

Personality disorders are a set of personality traits that are maladaptive and interfere with normal functioning in life. It is estimated that around 1 in 20 people have a personality disorder, which are typically categorized into three clusters: Cluster A, which includes Odd or Eccentric disorders such as Paranoid, Schizoid, and Schizotypal; Cluster B, which includes Dramatic, Emotional, or Erratic disorders such as Antisocial, Borderline (Emotionally Unstable), Histrionic, and Narcissistic; and Cluster C, which includes Anxious and Fearful disorders such as Obsessive-Compulsive, Avoidant, and Dependent.

Paranoid individuals exhibit hypersensitivity and an unforgiving attitude when insulted, a reluctance to confide in others, and a preoccupation with conspiratorial beliefs and hidden meanings. Schizoid individuals show indifference to praise and criticism, a preference for solitary activities, and emotional coldness. Schizotypal individuals exhibit odd beliefs and magical thinking, unusual perceptual disturbances, and inappropriate affect. Antisocial individuals fail to conform to social norms, deceive others, and exhibit impulsiveness, irritability, and aggressiveness. Borderline individuals exhibit unstable interpersonal relationships, impulsivity, and affective instability. Histrionic individuals exhibit inappropriate sexual seductiveness, a need to be the center of attention, and self-dramatization. Narcissistic individuals exhibit a grandiose sense of self-importance, lack of empathy, and excessive need for admiration. Obsessive-compulsive individuals are occupied with details, rules, and organization to the point of hampering completion of tasks. Avoidant individuals avoid interpersonal contact due to fears of criticism or rejection, while dependent individuals have difficulty making decisions without excessive reassurance from others.

Personality disorders are difficult to treat, but a number of approaches have been shown to help patients, including psychological therapies such as dialectical behavior therapy and treatment of any coexisting psychiatric conditions.

Risk Factors for Repeated Suicide Attempts

Individuals who have previously attempted suicide are at an increased risk of making another attempt. Factors that contribute to this risk include a history of previous attempts, personality disorders, alcohol or drug abuse, previous psychiatric treatment, unemployment, lower social class, criminal record, history of violence, and being between the ages of 25 and 54, as well as being single, divorced, or separated. Rates of further suicide attempts in the year following an attempt are high, ranging from 15 to 25 percent. However, being married or having short stature does not appear to be a significant risk factor for repeated suicide attempts.

Urinary retention may be a side effect of tricyclic antidepressants, particularly with the use of Amitriptyline due to its anticholinergic properties. This can lead to symptoms such as tachycardia, dry mouth, and mydriasis. However, SSRIs like fluoxetine and SNRIs like venlafaxine are less likely to cause urinary retention and dry mouth. Benzodiazepines like diazepam do not have anticholinergic effects.

Tricyclic Antidepressants for Neuropathic Pain

Tricyclic antidepressants (TCAs) were once commonly used for depression, but their side-effects and toxicity in overdose have led to a decrease in their use. However, they are still widely used in the treatment of neuropathic pain, where smaller doses are typically required. TCAs such as low-dose amitriptyline are commonly used for the management of neuropathic pain and the prophylaxis of headache, while lofepramine has a lower incidence of toxicity in overdose. It is important to note that some TCAs, such as amitriptyline and dosulepin, are considered more dangerous in overdose than others.

Common side-effects of TCAs include drowsiness, dry mouth, blurred vision, constipation, urinary retention, and lengthening of the QT interval. When choosing a TCA for neuropathic pain, the level of sedation may also be a consideration. Amitriptyline, clomipramine, dosulepin, and trazodone are more sedative, while imipramine, lofepramine, and nortriptyline are less sedative. It is important to work with a healthcare provider to determine the appropriate TCA and dosage for the individual’s specific needs.

Schizophrenia Risk Factors

Schizophrenia is a mental disorder that affects a person’s ability to think, feel, and behave clearly. The risk of developing schizophrenia is influenced by various factors, including heavy cannabis use, marital status, socioeconomic status, and genetics.

According to the Swedish conscript study, heavy cannabis users have a sevenfold increase in the risk of developing schizophrenia. However, it is unclear whether cannabis use directly causes schizophrenia or if there are other underlying factors at play.

Marital status also appears to be a factor in schizophrenia risk, with unmarried and divorced individuals being twice as likely to develop the disorder compared to married or widowed individuals. This may be due to the alienating effects of schizophrenia rather than any causal relationship with being single.

Additionally, people with schizophrenia are more likely to be in the lowest socioeconomic groups. While poverty may not directly cause schizophrenia, it may increase the risk of exposure to biological factors or social stressors that could trigger the illness in susceptible individuals.

Finally, genetics also play a significant role in schizophrenia risk, with monozygotic twins having a 50% concordance rate and 10% of offspring being affected. This suggests a strong inheritance component to the disorder.

Overall, while the exact causes of schizophrenia are not fully understood, it is clear that multiple factors contribute to its development.

Management of Bipolar Depression with Mania or Hypomania

According to the latest NICE guideline CG85, patients with bipolar depression presenting with mania or hypomania should have their lithium levels checked and consider adding an antipsychotic such as haloperidol, olanzapine, quetiapine or risperidone. Therefore, checking the lithium levels and considering adding olanzapine is the correct answer in this case.

Stopping lithium without checking the levels first is not recommended as it is a mood stabiliser and may be required for the patient. Starting haloperidol or risperidone without checking the lithium levels is also not recommended as the doctor must consider the patient’s lithium levels before adding an antipsychotic.

Differentiating between Malingering, Factitious Disorder, Conversion Disorder, and Hypochondriasis

When a patient presents with physical symptoms but there are no physical or imaging signs of significant illness, the likely diagnosis is malingering. In such cases, it is important to investigate the patient’s history to see if there could be other factors impacting their symptoms. Malingering is often suspected when a patient insists on staying in the hospital despite negative test results.

Factitious disorder refers to a patient who assumes the sick role without any physical or organic disease. These patients find satisfaction in being taken care of and often seek frequent outpatient visits and psychotherapy.

Factitious or induced illness is similar to factitious disorder, but it involves a patient seeking the sick role vicariously through a second patient. For example, a mother suffering from factitious disorder may abuse her child so that she can bring the child to the doctor for treatment. The patient assumes the sick role by proxy through the child.

Conversion disorder refers to the manifestation of psychological illness as neurologic pathology. Patients with conversion disorder suffer from symptoms such as weakness, numbness, blindness, or paralysis as a result of underlying psychiatric illness. They are often not bothered by their symptoms, a condition known as la belle indifférence.

Hypochondriasis refers to the fear of having a medical illness despite negative tests and reassurance. It is not associated with secondary gain.

Pseudodementia, which is characterized by global memory loss rather than short-term memory loss, can be mistaken for dementia but is actually a symptom of severe depression.

The correct diagnosis in this case is depression, as the patient’s symptoms are consistent with pseudodementia, which is a common mimic for dementia in elderly patients. While some cognitive impairment is present, the key feature is a global memory loss affecting both short and long-term memory over a short period of four weeks, with reluctance to engage in clinical assessment. The recent loss of the patient’s husband also suggests a severe reactive depressive episode.

Alzheimer’s dementia is a possible differential diagnosis due to the patient’s age, but it tends to present more gradually with selective impairment of short-term memory and relative sparing of longer-term memories.

Frontotemporal lobe dementia is less likely in this case as it tends to present with more dramatic behavioral changes or emotional disinhibition.

Lewy body dementia shares some symptoms with this case, such as impaired cognition and visual hallucinations. However, the specific hallucination of the patient’s husband is more likely related to grief and depression, which is supported by the relatively short duration of symptoms. Question stems that describe Lewy body dementia may also provide clues towards a movement disorder.

Differentiating between Depression and Dementia

Depression and dementia are two conditions that can have similar symptoms, making it difficult to distinguish between the two. However, there are certain factors that can suggest a diagnosis of depression over dementia.

One of the key factors is the duration and onset of symptoms. Depression often has a short history and a rapid onset, whereas dementia tends to develop slowly over time. Additionally, biological symptoms such as weight loss and sleep disturbance are more commonly associated with depression than dementia.

Patients with depression may also express concern about their memory, but they are often reluctant to take tests and may be disappointed with the results. In contrast, patients with dementia may not be aware of their memory loss or may not express concern about it.

The mini-mental test score can also be variable in patients with depression, whereas in dementia, there is typically a global memory loss, particularly in recent memory.

In summary, while depression and dementia can have overlapping symptoms, careful consideration of the duration and onset of symptoms, biological symptoms, patient concerns, and cognitive testing can help differentiate between the two conditions.

Aripiprazole is the most suitable medication to try for this patient as it has the least side effects among atypical antipsychotics, especially in terms of prolactin elevation. This is important as the patient’s nipple discharge is likely caused by high prolactin levels. Chlorpromazine, a typical antipsychotic, is not recommended as it has a higher risk of extrapyramidal side effects. Clozapine, another atypical antipsychotic, is not appropriate for this patient as it is only used for treatment-resistant schizophrenia and requires two other antipsychotics to be trialled first. Haloperidol, a typical antipsychotic, is also not recommended due to its higher risk of extrapyramidal side effects.

Atypical antipsychotics are now recommended as the first-line treatment for patients with schizophrenia, as per the 2005 NICE guidelines. These medications have the advantage of significantly reducing extrapyramidal side-effects. However, they can also cause adverse effects such as weight gain, hyperprolactinaemia, and in the case of clozapine, agranulocytosis. The Medicines and Healthcare products Regulatory Agency has issued warnings about the increased risk of stroke and venous thromboembolism when antipsychotics are used in elderly patients. Examples of atypical antipsychotics include clozapine, olanzapine, risperidone, quetiapine, amisulpride, and aripiprazole.

Clozapine, one of the first atypical antipsychotics, carries a significant risk of agranulocytosis and requires full blood count monitoring during treatment. Therefore, it should only be used in patients who are resistant to other antipsychotic medication. The BNF recommends introducing clozapine if schizophrenia is not controlled despite the sequential use of two or more antipsychotic drugs, one of which should be a second-generation antipsychotic drug, each for at least 6-8 weeks. Adverse effects of clozapine include agranulocytosis, neutropaenia, reduced seizure threshold, constipation, myocarditis, and hypersalivation. Dose adjustment of clozapine may be necessary if smoking is started or stopped during treatment.

Lithium levels should be monitored weekly after a change in dose until they become stable. This means that after an increase in lithium dose, the levels should be checked again after one week, and then weekly until they stabilize. The ideal time to check lithium levels is 12 hours after the dose is taken. Waiting for a month after a dose adjustment is too long, while checking after three days is too soon. Once the levels become stable, they can be checked every three months for the first year. After a year, if the levels remain stable, low-risk patients can have their lithium testing reduced to every six months, according to the BNF. However, NICE guidance recommends that three-monthly testing should continue indefinitely. Additionally, patients on lithium should have their thyroid function tests monitored every six months.

Lithium is a medication used to stabilize mood in individuals with bipolar disorder and as an adjunct in treatment-resistant depression. It has a narrow therapeutic range of 0.4-1.0 mmol/L and is primarily excreted by the kidneys. The mechanism of action is not fully understood, but it is believed to interfere with inositol triphosphate and cAMP formation. Adverse effects may include nausea, vomiting, diarrhea, fine tremors, nephrotoxicity, thyroid enlargement, ECG changes, weight gain, idiopathic intracranial hypertension, leucocytosis, hyperparathyroidism, and hypercalcemia.

Monitoring of patients taking lithium is crucial to prevent adverse effects and ensure therapeutic levels. It is recommended to check lithium levels 12 hours after the last dose and weekly after starting or changing the dose until levels are stable. Once established, lithium levels should be checked every three months. Thyroid and renal function should be monitored every six months. Patients should be provided with an information booklet, alert card, and record book to ensure proper management of their medication. Inadequate monitoring of patients taking lithium is common, and guidelines have been issued to address this issue.

Differentiating Schizophrenia from Other Mental Health Conditions

The patient’s disordered speech, derogatory hallucinations, and delusions about the television reading his thoughts are indicative of schizophrenia. These symptoms are often accompanied by thoughts of persecution or paranoia, which are known as first rank symptoms.

A manic episode is less likely as there is no history of overspending, pressured speech, or flight of thoughts. Similarly, endogenous depression is unlikely as neologisms and incoherent speech are not common presenting symptoms.

Drug-induced psychosis is also unlikely as neologisms and delusions about being a spy are not typical symptoms. Alcohol intoxication is also less likely as there is no evidence of alcohol involvement in this presentation or previous visits to Casualty.

Therefore, based on the symptoms presented, schizophrenia is the most likely diagnosis.

Managing Mania in Bipolar Disorder: Treatment Options

When a patient with bipolar disorder develops mania while on an antidepressant and antipsychotic, it is important to adjust their medication regimen. According to NICE guideline CG185, the first step is to stop the antidepressant. In this case, the patient was on olanzapine and fluoxetine, so the fluoxetine should be discontinued.

While lithium is a first-line mood stabilizer for bipolar disorder, it is contraindicated in this patient as she is trying to conceive. Instead, the patient could be switched from olanzapine to quetiapine, another antipsychotic that is similar in effectiveness.

It is important not to stop both the antipsychotic and antidepressant, as this could worsen the patient’s condition. By adjusting the medication regimen, the patient can be effectively managed during a manic episode.

The woman’s alternating episodes of hypomania and severe depression suggest that she has type 2 bipolar disorder. There are no indications of an anxiety disorder, and the severity of her symptoms is not consistent with cyclothymia. Major depressive disorder is also not a likely diagnosis, as she experiences ‘highs’ consistent with hypomania. Type 1 bipolar disorder is also unlikely, as her ‘high’ periods are more in line with hypomania rather than full-blown mania.

Understanding Bipolar Disorder

Bipolar disorder is a mental health condition that is characterized by alternating periods of mania/hypomania and depression. It typically develops in the late teen years and has a lifetime prevalence of 2%. There are two recognized types of bipolar disorder: type I, which involves mania and depression, and type II, which involves hypomania and depression.

Mania and hypomania both refer to abnormally elevated mood or irritability, but mania is more severe and can include psychotic symptoms for 7 days or more. Hypomania, on the other hand, involves decreased or increased function for 4 days or more. The presence of psychotic symptoms suggests mania.

Management of bipolar disorder may involve psychological interventions specifically designed for the condition, as well as medication. Lithium is the mood stabilizer of choice, but valproate can also be used. Antipsychotic therapy, such as olanzapine or haloperidol, may be used to manage mania/hypomania, while fluoxetine is the antidepressant of choice for depression. It is important to address any co-morbidities, as there is an increased risk of diabetes, cardiovascular disease, and COPD in individuals with bipolar disorder.

If symptoms suggest hypomania, routine referral to the community mental health team (CMHT) is recommended. However, if there are features of mania or severe depression, an urgent referral to the CMHT should be made. Understanding bipolar disorder and its management is crucial for healthcare professionals to provide appropriate care and support for individuals with this condition.

Differentiating between Conduct Disorder, Major Depression, Oppositional Defiant Disorder, Antisocial Disorder, and Manic Episode

Conduct Disorder, Major Depression, Oppositional Defiant Disorder, Antisocial Disorder, and Manic Episode are all mental health conditions that can present with similar symptoms. However, each disorder has its own unique characteristics that differentiate it from the others.

Conduct Disorder is a disorder that affects individuals under the age of 18 and is associated with disruptive, bullying behavior and often torture of animals. It is characterized by repetitive behavior that violates the rights of others.

Major Depression is associated with depressed mood, in addition to five of the following symptoms: sleep changes, loss of interest in previous hobbies or activities, guilt, decreased energy, difficulty concentrating, changes in appetite, sluggishness, and suicidal thoughts persisting for 2 weeks.

Oppositional Defiant Disorder is characterized by behavior in opposition to authority, but there is no violation of the rights of others or extreme behavior such as bullying or animal cruelty.

Antisocial Disorder is diagnosed in individuals who are 18 or older and exhibit signs of Conduct Disorder. It is characterized by a disregard for the rights of others and a lack of empathy.

Manic Episode is associated with elevated mood lasting for 7 days. These patients feel as though they have increased energy, do not need sleep, engage in risky sexual activity and sometimes illicit behavior, feel above the law or invincible, are easily distractible, have flight of fancy, are agitated, and have pressured speech.

It is important to differentiate between these disorders to ensure that individuals receive the appropriate treatment and support for their specific condition.

Deliberately inducing symptoms, such as a diabetic intentionally overdosing on insulin to experience hypoglycemia, is an instance of Munchausen’s syndrome.

Psychiatric Terms for Unexplained Symptoms

There are various psychiatric terms used to describe patients who exhibit symptoms for which no organic cause can be found. One such disorder is somatisation disorder, which involves the presence of multiple physical symptoms for at least two years, and the patient’s refusal to accept reassurance or negative test results. Another disorder is illness anxiety disorder, which is characterized by a persistent belief in the presence of an underlying serious disease, such as cancer, despite negative test results.

Conversion disorder is another condition that involves the loss of motor or sensory function, and the patient does not consciously feign the symptoms or seek material gain. Patients with this disorder may be indifferent to their apparent disorder, a phenomenon known as la belle indifference. Dissociative disorder, on the other hand, involves the process of ‘separating off’ certain memories from normal consciousness, and may manifest as amnesia, fugue, or stupor. Dissociative identity disorder (DID) is the most severe form of dissociative disorder and was previously known as multiple personality disorder.

Factitious disorder, also known as Munchausen’s syndrome, involves the intentional production of physical or psychological symptoms. Finally, malingering is the fraudulent simulation or exaggeration of symptoms with the intention of financial or other gain. Understanding these psychiatric terms can help healthcare professionals better diagnose and treat patients with unexplained symptoms.

Medical Investigations for Anorexia Nervosa: What to Expect

Anorexia nervosa is a serious eating disorder that can have significant impacts on a person’s physical health, including their cardiovascular system. When assessing a patient with anorexia nervosa, there are several medical investigations that may be considered. Here is what you can expect:

Electrocardiogram (ECG): This is a baseline test that assesses heart rate and the QT interval. Electrolyte imbalances caused by eating disorders can affect cardiac stability, so it’s important to check for any cardiovascular instability.

24-hour Holter monitor: This test may be considered if there is a problem with the baseline ECG or a history of cardiac symptoms such as palpitations.

Chest X-ray: This is not routinely required unless there are other respiratory symptoms present.

Serum prolactin: This test is not routinely required unless there is a history of galactorrhoea or amenorrhoea.

Transthoracic echocardiography: This test is not routinely required unless there are clinical indications for imaging of the heart.

Overall, medical investigations for anorexia nervosa are tailored to the individual patient’s needs and medical history. It’s important to work closely with a healthcare provider to determine which tests are necessary for each patient.

Chlordiazepoxide or diazepam are effective treatments for delirium tremens and alcohol withdrawal. Symptoms of alcohol withdrawal can include confusion, agitation, tremors, hallucinations, and autonomic dysfunction such as high blood pressure, sweating, and fever.

Chlordiazepoxide is the most appropriate answer for this scenario. While confusion, sweating, and agitation can be signs of infection, the patient’s alcohol history suggests that delirium tremens is the more likely diagnosis. IV antibiotics would not address the primary issue of alcohol withdrawal. The patient’s high blood pressure also suggests that infection is not the cause of their symptoms.

Intravenous hydration may be necessary if the patient is experiencing excessive fluid loss due to sweating, but it would not be the best treatment for alcohol withdrawal in this case.

Alcohol withdrawal occurs when an individual who has been consuming alcohol chronically suddenly stops or reduces their intake. Chronic alcohol consumption enhances the inhibitory effects of GABA in the central nervous system, similar to benzodiazepines, and inhibits NMDA-type glutamate receptors. However, alcohol withdrawal leads to the opposite effect, resulting in decreased inhibitory GABA and increased NMDA glutamate transmission. Symptoms of alcohol withdrawal typically start at 6-12 hours and include tremors, sweating, tachycardia, and anxiety. Seizures are most likely to occur at 36 hours, while delirium tremens, which includes coarse tremors, confusion, delusions, auditory and visual hallucinations, fever, and tachycardia, peak at 48-72 hours.

Patients with a history of complex withdrawals from alcohol, such as delirium tremens, seizures, or blackouts, should be admitted to the hospital for monitoring until their withdrawals stabilize. The first-line treatment for alcohol withdrawal is long-acting benzodiazepines, such as chlordiazepoxide or diazepam, which are typically given as part of a reducing dose protocol. Lorazepam may be preferable in patients with hepatic failure. Carbamazepine is also effective in treating alcohol withdrawal, while phenytoin is said to be less effective in treating alcohol withdrawal seizures.

The gradual onset of schizophrenia is associated with a worse long-term outcome, making it a poor prognostic indicator for this patient. However, her gender (being female) and good pre-illness functioning are both positive prognostic indicators. Additionally, her predominant positive symptoms (auditory hallucinations and delusions) suggest a better prognosis compared to predominant negative symptoms. Lastly, being diagnosed at a younger age (such as in her teens) would have resulted in a poorer prognosis.

Schizophrenia is a mental disorder that can have varying prognosis depending on certain factors. Some indicators associated with a poor prognosis include a strong family history of the disorder, a gradual onset of symptoms, a low IQ, a prodromal phase of social withdrawal, and a lack of an obvious precipitant. These factors can contribute to a more severe and chronic course of the illness, making it more difficult to manage and treat. It is important for individuals with schizophrenia and their loved ones to be aware of these indicators and seek appropriate treatment and support.

Understanding Tardive Dyskinesia and its Association with Antipsychotic Drugs

Tardive dyskinesia is a disorder characterized by involuntary and repetitive movements, including lip puckering, excessive blinking, and pursing of the lips. This condition is commonly associated with the use of typical (older generation) antipsychotics such as haloperidol, prochlorperazine, and flupentixol. However, newer generation (atypical) antipsychotics like olanzapine, quetiapine, risperidone, and clozapine have a lower risk of causing tardive dyskinesia.

If tardive dyskinesia is diagnosed, the causative drug should be discontinued. It is important to note that the dyskinesia may persist for months after drug withdrawal and may even be permanent. Metformin is not linked to tardive dyskinesia.

Risperidone is an atypical antipsychotic used to treat schizophrenia, bipolar disorder, and autism. Current evidence suggests that the risk of developing tardive dyskinesia is lower than with typical antipsychotic use. To prevent tardive dyskinesia in chronic psychoses, it is recommended to use the lowest effective dose for the shortest possible time, while balancing the fact that increased doses are more beneficial to prevent recurrence.